Moreover, real-world evidence derived from the US Collaborative Network of TriNetX, which analyzed data from individuals with T2DM aged 18 years who initiated tirzepatide or a GLP-1 RA between June 1, 2022, and June 30, 2023, suggests that tirzepatide reduces the risk of all-cause mortality by 42%, MACE by 20%, and major adverse kidney events by 46% [84]
Combining these therapies is generally safe with medical supervision, making them a promising option for midlife women struggling with hormonal weight gain
Recurrent nocturnal hypoxic episodes promote oxidative stress and inflammatory activation, characterized by elevated TNF- , IL-6, and C-reactive protein levels (35)
10.1016/j.physbeh.2011.04.005 107 Wilson-PrezH
By regulating blood sugar levels, Ozempic is particularly suitable for individuals with type 2 diabetes or prediabetes, addressing weight management challenges associated with insulin resistance